临床数据-话题@MedSci

#临床数据#

91篇内容 | 2711人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2016710, encodeId=ea892016e10a5, content=<a href='/topic/show?id=75a2228481a' target=_blank style='color:#2F92EE;'>#临床数据#</a>, objectTitle=关注！ASCO大会上的中国创新药全新临床数据, objectType=article, longId=138482, objectId=6714138482ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6714138482ca, replyNumber=0, likeNumber=72, createdTime=2019-03-01, rootId=0, userName=chenlianhui, userId=fa4f352, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6714138482ca, moduleTitle=关注！ASCO大会上的中国创新药全新临床数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6714138482ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016706, encodeId=c5652016e0647, content=<a href='/topic/show?id=75a2228481a' target=_blank style='color:#2F92EE;'>#临床数据#</a>, objectTitle=慢性肾病相关贫血新药vadadustat展现出色2期临床数据, objectType=article, longId=114459, objectId=9e491144599a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e491144599a, replyNumber=0, likeNumber=65, createdTime=2018-03-14, rootId=0, userName=chenlianhui, userId=fa4f352, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e491144599a, moduleTitle=慢性肾病相关贫血新药vadadustat展现出色2期临床数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e491144599a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016715, encodeId=c3912016e1511, content=<a href='/topic/show?id=75a2228481a' target=_blank style='color:#2F92EE;'>#临床数据#</a>, objectTitle=柳叶刀公布了Kyowa Kirin公司CCR4单抗Poteligeo 治疗皮肤T细胞淋巴瘤的III期临床数据, objectType=article, longId=146735, objectId=31ee146e35d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31ee146e35d9, replyNumber=0, likeNumber=100, createdTime=2018-10-09, rootId=0, userName=chenlianhui, userId=fa4f352, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31ee146e35d9, moduleTitle=柳叶刀公布了Kyowa Kirin公司CCR4单抗Poteligeo 治疗皮肤T细胞淋巴瘤的III期临床数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31ee146e35d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016711, encodeId=65de2016e1143, content=<a href='/topic/show?id=75a2228481a' target=_blank style='color:#2F92EE;'>#临床数据#</a>, objectTitle=曲马多治疗术后疼痛的III期临床数据, objectType=article, longId=138881, objectId=706b138881e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=706b138881e9, replyNumber=0, likeNumber=62, createdTime=2019-03-06, rootId=0, userName=chenlianhui, userId=fa4f352, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=706b138881e9, moduleTitle=曲马多治疗术后疼痛的III期临床数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=706b138881e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016709, encodeId=2a622016e099f, content=<a href='/topic/show?id=75a2228481a' target=_blank style='color:#2F92EE;'>#临床数据#</a>, objectTitle=倒计时2天|仅剩3个免费席位！【科室临床数据库我的科研引擎】沙龙诚邀您的莅临！, objectType=article, longId=120822, objectId=2d8a12082237, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d8a12082237, replyNumber=0, likeNumber=47, createdTime=2018-09-17, rootId=0, userName=chenlianhui, userId=fa4f352, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d8a12082237, moduleTitle=倒计时2天|仅剩3个免费席位！【科室临床数据库我的科研引擎】沙龙诚邀您的莅临！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d8a12082237)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016703, encodeId=48692016e0388, content=<a href='/topic/show?id=75a2228481a' target=_blank style='color:#2F92EE;'>#临床数据#</a>, objectTitle=J Endod：牙髓再生治疗的临床数据：是即刻还是延迟诱导再生？, objectType=article, longId=111411, objectId=814c11141196, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=814c11141196, replyNumber=0, likeNumber=77, createdTime=2017-10-26, rootId=0, userName=chenlianhui, userId=fa4f352, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=814c11141196, moduleTitle=J Endod：牙髓再生治疗的临床数据：是即刻还是延迟诱导再生？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=814c11141196)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016708, encodeId=c0162016e08b1, content=<a href='/topic/show?id=75a2228481a' target=_blank style='color:#2F92EE;'>#临床数据#</a>, objectTitle=仅限30席！第二期【科室临床数据库我的科研引擎】沙龙诚邀您的莅临！, objectType=article, longId=118707, objectId=1425118e0702, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1425118e0702, replyNumber=0, likeNumber=45, createdTime=2018-08-22, rootId=0, userName=chenlianhui, userId=fa4f352, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1425118e0702, moduleTitle=仅限30席！第二期【科室临床数据库我的科研引擎】沙龙诚邀您的莅临！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1425118e0702)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016707, encodeId=34702016e073a, content=<a href='/topic/show?id=75a2228481a' target=_blank style='color:#2F92EE;'>#临床数据#</a>, objectTitle=阿斯利康承认子公司抗癌药临床数据造假，刚获突破性疗法认定, objectType=article, longId=116767, objectId=4036116e673e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4036116e673e, replyNumber=0, likeNumber=55, createdTime=2018-01-03, rootId=0, userName=chenlianhui, userId=fa4f352, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4036116e673e, moduleTitle=阿斯利康承认子公司抗癌药临床数据造假，刚获突破性疗法认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4036116e673e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016702, encodeId=40cd2016e02f7, content=<a href='/topic/show?id=75a2228481a' target=_blank style='color:#2F92EE;'>#临床数据#</a>, objectTitle=收购2家公司，收揽**数据人才，苹果要把核心临床数据整合到iPhone上, objectType=article, longId=104024, objectId=7818104024ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7818104024ab, replyNumber=0, likeNumber=88, createdTime=2018-05-18, rootId=0, userName=chenlianhui, userId=fa4f352, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7818104024ab, moduleTitle=收购2家公司，收揽**数据人才，苹果要把核心临床数据整合到iPhone上, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7818104024ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016705, encodeId=b1ad2016e0592, content=<a href='/topic/show?id=75a2228481a' target=_blank style='color:#2F92EE;'>#临床数据#</a>, objectTitle=“科室临床数据库我的科研引擎”沙龙在沪完美举行, objectType=article, longId=112876, objectId=3ab41128e6d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ab41128e6d2, replyNumber=0, likeNumber=62, createdTime=2017-10-18, rootId=0, userName=chenlianhui, userId=fa4f352, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ab41128e6d2, moduleTitle=“科室临床数据库我的科研引擎”沙龙在沪完美举行, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3ab41128e6d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016704, encodeId=6c422016e0426, content=<a href='/topic/show?id=75a2228481a' target=_blank style='color:#2F92EE;'>#临床数据#</a>, objectTitle=Regen Lab发布有关运用细胞基质技术治疗皮肤病的全新临床数据, objectType=article, longId=112818, objectId=36b211281810, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36b211281810, replyNumber=0, likeNumber=72, createdTime=2018-06-28, rootId=0, userName=chenlianhui, userId=fa4f352, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36b211281810, moduleTitle=Regen Lab发布有关运用细胞基质技术治疗皮肤病的全新临床数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36b211281810)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016700, encodeId=db8b2016e003c, content=<a href='/topic/show?id=75a2228481a' target=_blank style='color:#2F92EE;'>#临床数据#</a>, objectTitle=临床数据造假怎么处理？CFDA正式发布意见！, objectType=article, longId=99649, objectId=3e999964943, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e999964943, replyNumber=0, likeNumber=79, createdTime=2018-01-08, rootId=0, userName=chenlianhui, userId=fa4f352, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e999964943, moduleTitle=临床数据造假怎么处理？CFDA正式发布意见！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e999964943)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016699, encodeId=76a12016699c9, content=<a href='/topic/show?id=75a2228481a' target=_blank style='color:#2F92EE;'>#临床数据#</a>, objectTitle=NEJM：美国临床数据库使用情况调查, objectType=article, longId=94035, objectId=543794035c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=543794035c9, replyNumber=0, likeNumber=47, createdTime=2017-04-06, rootId=0, userName=chenlianhui, userId=fa4f352, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=543794035c9, moduleTitle=NEJM：美国临床数据库使用情况调查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=543794035c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016701, encodeId=94412016e01a0, content=<a href='/topic/show?id=75a2228481a' target=_blank style='color:#2F92EE;'>#临床数据#</a>, objectTitle=全球胰高血糖素受体抗体临床数据公布, objectType=article, longId=102760, objectId=6532102e6059, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6532102e6059, replyNumber=0, likeNumber=60, createdTime=2017-08-11, rootId=0, userName=chenlianhui, userId=fa4f352, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6532102e6059, moduleTitle=全球胰高血糖素受体抗体临床数据公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6532102e6059)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016696, encodeId=5d4c201669652, content=<a href='/topic/show?id=75a2228481a' target=_blank style='color:#2F92EE;'>#临床数据#</a>, objectTitle=Micell Technologies公布MiStent积极的五年期临床数据, objectType=article, longId=81610, objectId=d5e281610db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5e281610db, replyNumber=0, likeNumber=83, createdTime=2017-06-22, rootId=0, userName=chenlianhui, userId=fa4f352, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5e281610db, moduleTitle=Micell Technologies公布MiStent积极的五年期临床数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5e281610db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016697, encodeId=5455201669e45, content=<a href='/topic/show?id=75a2228481a' target=_blank style='color:#2F92EE;'>#临床数据#</a>, objectTitle=瞪口呆！赛诺菲和诺华在临床数据公开程度排名垫底, objectType=article, longId=81957, objectId=12918195eef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12918195eef, replyNumber=0, likeNumber=58, createdTime=2017-05-18, rootId=0, userName=chenlianhui, userId=fa4f352, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12918195eef, moduleTitle=瞪口呆！赛诺菲和诺华在临床数据公开程度排名垫底, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=12918195eef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016695, encodeId=afcf2016695ed, content=<a href='/topic/show?id=75a2228481a' target=_blank style='color:#2F92EE;'>#临床数据#</a>, objectTitle=Exelixis公布cabozantinib联合nivolumab治疗进展期泌尿系统肿瘤临床数据, objectType=article, longId=80910, objectId=09fc8091087, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=09fc8091087, replyNumber=0, likeNumber=66, createdTime=2017-02-20, rootId=0, userName=chenlianhui, userId=fa4f352, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=09fc8091087, moduleTitle=Exelixis公布cabozantinib联合nivolumab治疗进展期泌尿系统肿瘤临床数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=09fc8091087)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016698, encodeId=2d182016698d2, content=<a href='/topic/show?id=75a2228481a' target=_blank style='color:#2F92EE;'>#临床数据#</a>, objectTitle=赛诺菲和诺华在临床数据公开程度排名垫底！该改变态度了！, objectType=article, longId=82682, objectId=7b4b8268205, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b4b8268205, replyNumber=0, likeNumber=59, createdTime=2017-04-15, rootId=0, userName=chenlianhui, userId=fa4f352, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b4b8268205, moduleTitle=赛诺菲和诺华在临床数据公开程度排名垫底！该改变态度了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b4b8268205)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016691, encodeId=3f6c20166915b, content=<a href='/topic/show?id=75a2228481a' target=_blank style='color:#2F92EE;'>#临床数据#</a>, objectTitle=Bluebird临床数据不甚理想基因疗法任重而道远, objectType=article, longId=60597, objectId=74836059e7a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74836059e7a, replyNumber=0, likeNumber=65, createdTime=2016-08-11, rootId=0, userName=chenlianhui, userId=fa4f352, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74836059e7a, moduleTitle=Bluebird临床数据不甚理想基因疗法任重而道远, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74836059e7a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2016694, encodeId=b1c92016694ff, content=<a href='/topic/show?id=75a2228481a' target=_blank style='color:#2F92EE;'>#临床数据#</a>, objectTitle=ASCO 2016：PD-1类药物在肝癌中应用临床数据解析, objectType=article, longId=70431, objectId=25ffe04313d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25ffe04313d, replyNumber=0, likeNumber=49, createdTime=2017-04-09, rootId=0, userName=chenlianhui, userId=fa4f352, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25ffe04313d, moduleTitle=ASCO 2016：PD-1类药物在肝癌中应用临床数据解析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25ffe04313d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

临床数据

2020-05-29

chenlianhui (审核中...)

前往app查看评论内容

#临床数据#

关注！ASCO大会上的中国创新药全新临床数据

2019-03-01

chenlianhui (审核中...)

前往app查看评论内容

#临床数据#

慢性肾病相关贫血新药vadadustat展现出色2期临床数据

2018-03-14

chenlianhui (审核中...)

前往app查看评论内容

#临床数据#

柳叶刀公布了Kyowa Kirin公司CCR4单抗Poteligeo 治疗皮肤T细胞淋巴瘤的III期临床数据

2018-10-09

chenlianhui (审核中...)

前往app查看评论内容

#临床数据#

曲马多治疗术后疼痛的III期临床数据

2019-03-06

chenlianhui (审核中...)

前往app查看评论内容

#临床数据#

倒计时2天|仅剩3个免费席位！【科室临床数据库我的科研引擎】沙龙诚邀您的莅临！

2018-09-17

chenlianhui (审核中...)

前往app查看评论内容

#临床数据#

J Endod：牙髓再生治疗的临床数据：是即刻还是延迟诱导再生？

2017-10-26

chenlianhui (审核中...)

前往app查看评论内容

#临床数据#

仅限30席！第二期【科室临床数据库我的科研引擎】沙龙诚邀您的莅临！

2018-08-22

chenlianhui (审核中...)

前往app查看评论内容

#临床数据#

阿斯利康承认子公司抗癌药临床数据造假，刚获突破性疗法认定

2018-01-03

chenlianhui (审核中...)

前往app查看评论内容

#临床数据#

收购2家公司，收揽**数据人才，苹果要把核心临床数据整合到iPhone上

2018-05-18

chenlianhui (审核中...)

前往app查看评论内容

#临床数据#

“科室临床数据库我的科研引擎”沙龙在沪完美举行

2017-10-18

chenlianhui (审核中...)

前往app查看评论内容

#临床数据#

Regen Lab发布有关运用细胞基质技术治疗皮肤病的全新临床数据

2018-06-28

chenlianhui (审核中...)

前往app查看评论内容

#临床数据#

临床数据造假怎么处理？CFDA正式发布意见！

2018-01-08

chenlianhui (审核中...)

前往app查看评论内容

#临床数据#

NEJM：美国临床数据库使用情况调查

2017-04-06

chenlianhui (审核中...)

前往app查看评论内容

#临床数据#

全球胰高血糖素受体抗体临床数据公布

2017-08-11

chenlianhui (审核中...)

前往app查看评论内容

#临床数据#

Micell Technologies公布MiStent积极的五年期临床数据

2017-06-22

chenlianhui (审核中...)

前往app查看评论内容

#临床数据#

瞪口呆！赛诺菲和诺华在临床数据公开程度排名垫底

2017-05-18

chenlianhui (审核中...)

前往app查看评论内容

#临床数据#

Exelixis公布cabozantinib联合nivolumab治疗进展期泌尿系统肿瘤临床数据

2017-02-20

chenlianhui (审核中...)

前往app查看评论内容

#临床数据#

赛诺菲和诺华在临床数据公开程度排名垫底！该改变态度了！

2017-04-15

chenlianhui (审核中...)

前往app查看评论内容

#临床数据#

Bluebird临床数据不甚理想基因疗法任重而道远

2016-08-11

chenlianhui (审核中...)

前往app查看评论内容

#临床数据#

ASCO 2016：PD-1类药物在肝癌中应用临床数据解析

2017-04-09

科室
- - 订阅+
  - 更多科室
工具
服务